{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T05:25:08Z","timestamp":1792301108009,"version":"4.4.0"},"update-to":[{"DOI":"10.1002\/14651858.cd010285.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T00:00:00Z","timestamp":1597881600000}}],"reference-count":191,"publisher":"Wiley","issue":"8","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010285.pub3","type":"journal-article","created":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T22:21:22Z","timestamp":1597962082000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Antibiotic therapy for pelvic inflammatory disease"],"prefix":"10.1002","volume":"2020","author":[{"given":"Ricardo F","family":"Savaris","sequence":"additional","affiliation":[{"name":"Ginecologia e Obstetricia; UFRGS-FAMED; Porto Alegre Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele G","family":"Fuhrich","sequence":"additional","affiliation":[{"name":"Ginecologia e Obstetricia; UFRGS-FAMED; Porto Alegre Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackson","family":"Maissiat","sequence":"additional","affiliation":[{"name":"School of Medicine; Universidade Federal do Rio Grande do Sul; Porto Alegre Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui V","family":"Duarte","sequence":"additional","affiliation":[{"name":"Liverpool Reviews and Implementation Group; University of Liverpool; Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Ross","sequence":"additional","affiliation":[{"name":"Department of G U Medicine; The Whittall Street Clinic; Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,8,20]]},"reference":[{"issue":"5A","key":"10.1002\/14651858.CD010285.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"148S","DOI":"10.1016\/0002-9343(89)90046-6","article-title":"Comparison of parenteral ciprofloxacin with clindamycin-gentamicin in the treatment of pelvic infection","volume":"87","author":"Apuzzio","year":"1989","journal-title":"American Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD010285.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/clinids\/24.2.170","article-title":"Oral clindamycin and ciprofloxacin versus intramuscular ceftriaxone and oral doxycycline in the treatment of mild-to-moderate pelvic inflammatory disease in outpatients","volume":"24","author":"Arredondo","year":"1997","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD010285.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejogrb.2013.08.012","article-title":"Single daily dose of moxifloxacin versus ofloxacin plus metronidazole as a new treatment approach to uncomplicated pelvic inflammatory disease: a multicentre prospective randomized trial","volume":"171","author":"A\u015ficio\u011flu","year":"2013","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"issue":"1-2","key":"10.1002\/14651858.CD010285.pub3-BIB0004|cit4","first-page":"19","article-title":"Acute pelvic inflammatory disease: comparison of therapeutic protocols","volume":"48","author":"Balbi","year":"1996","journal-title":"Minerva Ginecologica"},{"issue":"1","key":"10.1002\/14651858.CD010285.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/147323000303100108","article-title":"Efficacy and safety of azithromycin as monotherapy or combined with metronidazole compared with two standard multidrug regimens for the treatment of acute pelvic inflammatory disease","volume":"31","author":"Bevan","year":"2003","journal-title":"Journal of International Medical Research"},{"issue":"10","key":"10.1002\/14651858.CD010285.pub3-BIB0006|cit6","first-page":"699","article-title":"Treatment of upper genital infections in women. Multicenter study of the comparative efficacy and tolerance of an amoxicillin-clavulanic acid combination and of a triple antibiotic combination","volume":"84","author":"Buisson","year":"1989","journal-title":"Revue Francaise de Gynecologie et d'Obstetrique"},{"key":"10.1002\/14651858.CD010285.pub3-BIB0007|cit7","first-page":"248","article-title":"Efficacy of different antibiotics in the treatment of pelvic inflammatory disease","volume":"72","author":"Burchell","year":"1987","journal-title":"South African Medical Journal"},{"issue":"5 Pt 2","key":"10.1002\/14651858.CD010285.pub3-BIB0008|cit8","first-page":"665","article-title":"The drug combination amoxicillin-clavulanic acid compared to the triple combination ampicillin-gentamicin-metronidazole in the treatment of severe adnexal infections","volume":"34","author":"Ciraru-Vigneron","year":"1986","journal-title":"Pathologie Biologie"},{"issue":"5","key":"10.1002\/14651858.CD010285.pub3-BIB0009|cit9","first-page":"312","article-title":"Amoxycillin\/clavulanic acid ('Augmentin') compared with a combination of aminopenicillin, aminoglycoside and metronidazole in the treatment of pelvic inflammatory disease","volume":"5","author":"Ciraru-Vigneron","year":"1989","journal-title":"Pharmatherapeutica"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD010285.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2165\/00003495-198600312-00003","article-title":"Sulbactam\/ampicillin versus metronidazole\/gentamicin in the treatment of severe pelvic infections","volume":"31","author":"Crombleholme","year":"1986","journal-title":"Drugs"},{"issue":"2","key":"10.1002\/14651858.CD010285.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0002-9378(87)90321-8","article-title":"Ampicillin\/sulbactam versus metronidazole-gentamicin in the treatment of soft tissue pelvic infections","volume":"156","author":"Crombleholme","year":"1987","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"Suppl 5A","key":"10.1002\/14651858.CD010285.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"142S","DOI":"10.1016\/0002-9343(89)90045-4","article-title":"Efficacy of single-agent therapy for the treatment of acute pelvic inflammatory disease with ciprofloxacin","volume":"87","author":"Crombleholme","year":"1989","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD010285.pub3-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"A3","DOI":"10.1186\/ISRCTN51790058","article-title":"Is a short course of azithromycin effective in the treatment of mild to moderate pelvic inflammatory disease (PID)?","volume":"92 (Suppl)","author":"Dean","year":"2016","journal-title":"Sexually Transmitted Infections"},{"key":"10.1002\/14651858.CD010285.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1055\/s-2007-1022851","article-title":"Ciprofloxacin\/metronidazol vs. cefoxitin\/doxycyclin: vergleich zweier therapieschemata zur behandlung der akuten pelvinen infektion","volume":"54","author":"Fischbach","year":"1994","journal-title":"Geburtshilfe und Frauenheilkunde"},{"issue":"10","key":"10.1002\/14651858.CD010285.pub3-BIB0015|cit15","first-page":"941","article-title":"A comparison of the efficacy of and tolerance to Augmentin used alone and as one of three drugs used to treat acute upper genital tract infections. Results of a multicentre trial 152 cases","volume":"17","author":"Giraud","year":"1989","journal-title":"Contraception, Fertilite, Sexualite"},{"key":"10.1002\/14651858.CD010285.pub3-BIB0016|cit16","first-page":"66","article-title":"A comparison of ciprofloxacin with doxycycline plus metronidazole in the treatment of acute pelvic inflammatory disease","volume":"60","author":"Heinonen","year":"1989","journal-title":"Scandinavian Journal of Infectious Diseases. Supplementum"},{"issue":"4","key":"10.1002\/14651858.CD010285.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1093\/clinids\/19.4.720","article-title":"Comparison of three regimens recommended by the Centers for Disease Control and Prevention for the treatment of women hospitalized with acute pelvic inflammatory disease","volume":"19","author":"Hemsell","year":"1994","journal-title":"Clinical Infectious Diseases"},{"issue":"10","key":"10.1002\/14651858.CD010285.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1258\/ijsa.2008.008495","article-title":"A randomized double-blind comparison of moxifloxacin and doxycycline\/metronidazole\/ciprofloxacin in the treatment of acute, uncomplicated pelvic inflammatory disease","volume":"20","author":"Heystek","year":"2009","journal-title":"International Journal of STD & AIDS"},{"key":"10.1002\/14651858.CD010285.pub3-BIB0019|cit19","first-page":"607","article-title":"Quinolones in the treatment of uncomplicated salpingitis: ofloxacin\/metronidazole vs gentamicin\/clindamycin","volume":"VII.8a","author":"Hoyme","year":"1993","journal-title":"Infektionen in der Gyn\u00e4cologie und geburtshilfe"},{"key":"10.1002\/14651858.CD010285.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1111\/j.1471-0528.2010.02687.x","article-title":"Efficacy and safety of moxifloxacin in uncomplicated pelvic inflammatory disease: the MONALISA study","volume":"117","author":"Judlin","year":"2010","journal-title":"BJOG"},{"issue":"3","key":"10.1002\/14651858.CD010285.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/0002-9378(91)90528-Y","article-title":"Combination antimicrobial therapy in the treatment of acute pelvic inflammatory disease","volume":"164","author":"Landers","year":"1991","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD010285.pub3-BIB0022|cit22","first-page":"9","article-title":"Prospective randomized trial comparing the efficacy and the tolerance of clindamycin-gentamicin versus metronidazole-gentamicin in acute utero-adnexal infections in hospitalized patients","volume":"82","author":"Leboeuf","year":"1987","journal-title":"Revue Francaise de Gynecologie et d'Obstetrique"},{"issue":"12","key":"10.1002\/14651858.CD010285.pub3-BIB0023|cit23","first-page":"549","article-title":"Ciprofloxacin-tinidazole combination, fluconazole-azithromycin-secnidazole-kit and doxycycline-metronidazole combination therapy in syndromic management of pelvic inflammatory disease: a prospective randomized controlled trial","volume":"57","author":"Malhotra","year":"2003","journal-title":"Indian Journal of Medical Sciences"},{"issue":"2","key":"10.1002\/14651858.CD010285.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3109\/00016349209007970","article-title":"Comparative evaluation of clindamycin\/gentamicin and cefoxitin\/doxycycline for treatment of pelvic inflammatory disease: a multi-center trial","volume":"71","author":"Maria","year":"1992","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"Suppl A","key":"10.1002\/14651858.CD010285.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/jac\/26.suppl_A.37","article-title":"Comparison of cefotaxime, cefoxitin and clindamycin plus gentamicin in the treatment of uncomplicated and complicated pelvic inflammatory disease","volume":"26","author":"Martens","year":"1990","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"6","key":"10.1002\/14651858.CD010285.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/00007611-199306000-00002","article-title":"Multicenter randomized trial of ofloxacin versus cefoxitin and doxycycline in outpatient treatment of pelvic inflammatory disease","volume":"86","author":"Martens","year":"1993","journal-title":"Southern Medical Journal"},{"issue":"11","key":"10.1002\/14651858.CD010285.pub3-BIB0027|cit27","first-page":"821","article-title":"Comparative clinical study on ciprofloxacin and cefroxadine in the treatment of infections in obstetrics and gynecology [in Japanese]","volume":"36","author":"Okada","year":"1988","journal-title":"Chemotherapy"},{"issue":"6","key":"10.1002\/14651858.CD010285.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/sti.2005.019109","article-title":"Moxifloxacin versus ofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: results of a multicentre, double blind, randomised trial","volume":"82","author":"Ross","year":"2006","journal-title":"Sexually Transmitted Infections"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD010285.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1007\/BF01644220","article-title":"Cefotaxime in the treatment of female pelvic soft tissue infections","volume":"13","author":"Roy","year":"1985","journal-title":"Infection"},{"issue":"Suppl C","key":"10.1002\/14651858.CD010285.pub3-BIB0030|cit30","first-page":"53","article-title":"A comparison of the efficacy and safety of ceftizoxime with doxycycline versus conventional CDC therapies in the treatment of upper genital tract infection with or without a mass","volume":"12","author":"Roy","year":"1990","journal-title":"Clinical Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD010285.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/01.AOG.0000268801.90261.27","article-title":"Comparing ceftriaxone plus azithromycin or doxycycline for pelvic inflammatory disease: a randomized controlled trial","volume":"110","author":"Savaris","year":"2007","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD010285.pub3-BIB0032|cit32","first-page":"215","article-title":"Triple therapies versus clindamycin plus gentamicin in the treatment of acute pelvic inflammatory disease: a randomized controlled trial","volume":"14","author":"Sirayapiwat","year":"2002","journal-title":"Thai Journal of Obstetrics and Gynaecology"},{"issue":"7","key":"10.1002\/14651858.CD010285.pub3-BIB0033|cit33","first-page":"7","article-title":"A comparison of two antibiotic regiments for treatment of pelvic inflammatory disease","volume":"72","author":"Soper","year":"1988","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD010285.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/S0002-9378(85)80068-5","article-title":"Moxalactam versus clindamycin plus tobramycin in the treatment of obstetric and gynecologic infections","volume":"152","author":"Sweet","year":"1985","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD010285.pub3-BIB0035|cit35","first-page":"696","article-title":"Ciprofloxacin monotherapy for acute pelvic infections: a comparison with clindamycin plus gentamicin","volume":"78","author":"Thadepalli","year":"1991","journal-title":"Obstetrics and Gynaecology"},{"issue":"4","key":"10.1002\/14651858.CD010285.pub3-BIB0036|cit36","first-page":"513","article-title":"Treatment of acute non-chlamydial salpingitis. Study of the efficacy and tolerance of a single-therapy antibiotic: Augmentin","volume":"17","author":"Tison","year":"1988","journal-title":"Journal de Gynecologie, Obstetrique et Biologie de la Reproduction"},{"issue":"5","key":"10.1002\/14651858.CD010285.pub3-BIB0037|cit37","first-page":"867","article-title":"A randomized comparison of gentamicin-clindamycin and cefoxitin-doxycycline in the treatment of acute pelvic inflammatory disease","volume":"75","author":"Walters","year":"1990","journal-title":"Obstetrics and Gynecology"},{"issue":"5 Pt 2","key":"10.1002\/14651858.CD010285.pub3-BIB0038|cit38","first-page":"1390","article-title":"A randomized trial of ofloxacin versus cefoxitin and doxycycline in the outpatient treatment of acute salpingitis","volume":"164","author":"Cox","year":"1991","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD010285.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.ajog.2017.08.081","article-title":"Impact of metronidazole on clearance of anaerobes in women with acute pelvic inflammatory disease: the ACE trial","volume":"217","author":"Wiesenfeld","year":"2017","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD010285.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/1120009X.1989.11738933","article-title":"Piperacillin alone vs triple antibiotic combination in gynecological infections","volume":"1","author":"Acar","year":"1989","journal-title":"Journal of Chemotherapy"},{"issue":"8","key":"10.1002\/14651858.CD010285.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1185\/03007998009109479","article-title":"A comparison of two different dosages of pivampicillin and doxycycline in patients with gynaecological infections","volume":"6","author":"Andersson","year":"1980","journal-title":"Current Medical Research and Opinion"},{"issue":"8","key":"10.1002\/14651858.CD010285.pub3-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1080\/01443615.2018.1445706","article-title":"Effect of vaginal suppository on bacterial vaginitis based on Persian medicine (Iranian traditional medicine): a randomised double blind clinical study","volume":"38","author":"Baery","year":"2018","journal-title":"Journal of Obstetrics and Gynaecology"},{"issue":"5","key":"10.1002\/14651858.CD010285.pub3-BIB0043|cit43","first-page":"483","article-title":"Therapeutic trial of moxalactam in intra-abdominal sepsis and gynaecological infections","volume":"VIII","author":"Bartlett","year":"1982","journal-title":"Drugs under Experimental and Clinical Research"},{"issue":"3","key":"10.1002\/14651858.CD010285.pub3-BIB0044|cit44","first-page":"204","article-title":"Randomized, comparative trial of imipenem\/cilastatin and moxalactam in the treatment of serious obstetric and gynecologic infections","volume":"162","author":"Berkeley","year":"1986","journal-title":"Surgery, Gynecology & Obstetrics"},{"issue":"4","key":"10.1002\/14651858.CD010285.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1128\/AAC.24.4.500","article-title":"Randomized comparison of ceftazidime versus clindamycin-tobramycin in the treatment of obstetrical and gynecological infections","volume":"24","author":"Blanco","year":"1983","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1002\/14651858.CD010285.pub3-BIB0046|cit46","first-page":"63","article-title":"Second look laparoscopy after treatment of acute salpingitis with doxycycline\/benzylpenicillin procaine or trimethoprim-sulfamethoxazole","volume":"53","author":"Brihmer","year":"1988","journal-title":"Scandinavian Journal of Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD010285.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0028-2243(89)90011-7","article-title":"Second look laparoscopy; evaluation of two different antibiotic regimens after treatment of acute salpingitis","volume":"30","author":"Brihmer","year":"1989","journal-title":"European Journal of Obstetrics & Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD010285.pub3-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1186\/s13063-016-1683-8","article-title":"Gentamicin versus ceftriaxone for the treatment of gonorrhoea (G-TOG trial): study protocol for a randomised trial","volume":"17","author":"Brittain","year":"2016","journal-title":"Trials"},{"issue":"2","key":"10.1002\/14651858.CD010285.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2165\/00003495-198600312-00002","article-title":"Treatment of acute salpingitis with sulbactam\/ampicillin","volume":"31 Suppl","author":"Bruhat","year":"1986","journal-title":"Drugs"},{"issue":"2","key":"10.1002\/14651858.CD010285.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0020-7292(89)90091-X","article-title":"Treatment of acute salpingitis with sulbactam\/ampicillin","volume":"31 Suppl","author":"Bruhat","year":"1989","journal-title":"International Journal of Gynecology & Obstetrics"},{"issue":"3","key":"10.1002\/14651858.CD010285.pub3-BIB0051|cit51","first-page":"465","article-title":"A clinical trial with the new antibiotic combination piperacillin\/flucloxacillin used on gynaecological postoperative infections","volume":"38","author":"Bruno","year":"1985","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD010285.pub3-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1007\/s10096-017-2913-z","article-title":"Efficacy and safety of morinidazole in pelvic inflammatory disease: results of a multicenter, double-blind, randomized trial","volume":"36","author":"Cao","year":"2017","journal-title":"European Journal of Clinical Microbiology & Infectious Diseases"},{"issue":"4","key":"10.1002\/14651858.CD010285.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1185\/03007997309111668","article-title":"The use of oxyphenbutazone ('Tanderil') in acute pelvic inflammatory disease","volume":"1","author":"Carty","year":"1973","journal-title":"Current Medical Research and Opinion"},{"issue":"3","key":"10.1002\/14651858.CD010285.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/(SICI)1098-0997(1997)5:3<215::AID-IDOG4>3.0.CO;2-O","article-title":"Trospectomycin in acute pelvic inflammatory disease: a preliminary report","volume":"5","author":"Chatwani","year":"1997","journal-title":"Infectious Diseases in Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD010285.pub3-BIB0055|cit55","first-page":"154","article-title":"Mezlocillin versus doxycycline in the treatment of acute salpingitis","volume":"55","author":"Confino","year":"1988","journal-title":"Mount Sinai Journal of Medicine"},{"key":"10.1002\/14651858.CD010285.pub3-BIB0056|cit56","first-page":"733","article-title":"Efficacy of ampicillin and cefoxitin in the treatment of acute pelvic inflammatory disease. A comparative study","volume":"64","author":"De Beer","year":"1983","journal-title":"South African Medical Journal"},{"issue":"2","key":"10.1002\/14651858.CD010285.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S1569-9056(10)60483-6","article-title":"Azithromycin vs. clarithromycin and both combination in treatment of mycoplasma genitalium","volume":"9","author":"Drasa","year":"2010","journal-title":"European Urology Supplements"},{"issue":"5","key":"10.1002\/14651858.CD010285.pub3-BIB0058|cit58","first-page":"715","article-title":"A prospective randomized controlled trial of cefoxitin versus clindamycin-aminoglycoside in mixed anaerobic-aerobic infections","volume":"154","author":"Drusano","year":"1982","journal-title":"Surgery, Gynecology & Obstetrics"},{"issue":"6","key":"10.1002\/14651858.CD010285.pub3-BIB0059|cit59","first-page":"651","article-title":"Evaluation of doxycycline for the complementary treatment of acute inflammatory pelvic disease. A double-blind study","volume":"52","author":"Duarte","year":"1995","journal-title":"Revista Brasileira de Medicina do Esporte"},{"issue":"3","key":"10.1002\/14651858.CD010285.pub3-BIB0060|cit60","first-page":"349","article-title":"Ceftizoxime versus cefotaxime in the treatment of hospitalized patients with pelvic inflammatory disease","volume":"43","author":"Faro","year":"1988","journal-title":"Current Therapeutic Research"},{"issue":"4 Suppl","key":"10.1002\/14651858.CD010285.pub3-BIB0061|cit61","first-page":"911","article-title":"Treatment of Chlamydia trachomatis endometritis with josamycin","volume":"1","author":"Fedele","year":"1989","journal-title":"Journal of Chemotherapy"},{"issue":"12","key":"10.1002\/14651858.CD010285.pub3-BIB0062|cit62","first-page":"2637","article-title":"Effect of Fuyanshu capsules combined with antibiotics on inflammatory factors in patients with pelvic inflammatory disease","volume":"44","author":"Feng","year":"2019","journal-title":"Zhongguo Zhong Yao za Zhi [China Journal of Chinese Materia Medica]"},{"issue":"1","key":"10.1002\/14651858.CD010285.pub3-BIB0063|cit63","first-page":"41","article-title":"Imipenem versus netilmicin plus chloramphenicol in gynecological upper tract infections: a comparative study","volume":"5","author":"Frongillo","year":"1992","journal-title":"Chemotherapy"},{"issue":"1","key":"10.1002\/14651858.CD010285.pub3-BIB0064|cit64","first-page":"51","article-title":"Intravenous metronidazole or clindamycin with tobramycin for therapy of pelvic infections","volume":"57","author":"Gall","year":"1981","journal-title":"Obstetrics & Gynecology"},{"issue":"11 Suppl","key":"10.1002\/14651858.CD010285.pub3-BIB0065|cit65","first-page":"1091","article-title":"Therapeutic dilemmas in the treatment of pelvic infections","volume":"35","author":"Gall","year":"1990","journal-title":"Journal of Reproductive Medicine"},{"issue":"2","key":"10.1002\/14651858.CD010285.pub3-BIB0066|cit66","first-page":"282","article-title":"Comparative evaluation of clindamycin versus clindamycin plus tobramycin in the treatment of acute pelvic inflammatory disease","volume":"75","author":"Gall","year":"1990","journal-title":"Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD010285.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1055\/s-2007-1026119","article-title":"Treatment of acute salpingitis with tetracycline\/metronidazole with or without additional balneotherapy. Augmentan or ciprofloxacin\/metronidazole: a second-look-laparoscopy study","volume":"52","author":"Gerber","year":"1992","journal-title":"Geburtshilfe und Frauenheilkunde"},{"issue":"4","key":"10.1002\/14651858.CD010285.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000293333","article-title":"Comparison of ceftriaxone (1 x 1 g\/day) versus cefotaxime (3 x 1 g\/day) for gynecologic and obstetric infections. A randomized clinical trial","volume":"29","author":"Gerstner","year":"1990","journal-title":"Gynecologic and Obstetric Investigation"},{"issue":"8","key":"10.1002\/14651858.CD010285.pub3-BIB0069|cit69","first-page":"1","article-title":"Comparing ceftriaxone plus azithromycin or doxycycline for outpatient treatment in pelvic inflammatory disease","volume":"14","author":"Ghomian","year":"2012","journal-title":"Iranian Journal of Obstetrics, Gynecology and Infertility"},{"issue":"6","key":"10.1002\/14651858.CD010285.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1159\/000238140","article-title":"Ornidazole versus clindamycin: comparative evaluation in the treatment of 140 serious anaerobic infections","volume":"28","author":"Giamarellou","year":"1982","journal-title":"Chemotherapy"},{"issue":"1","key":"10.1002\/14651858.CD010285.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00007435-198001000-00006","article-title":"A trial of spectinomycin hydrochloride compared with aqueous penicillin G plus kanamycin for treatment of severe pelvic inflammatory disease","volume":"7","author":"Gibbs","year":"1980","journal-title":"Sexually Transmitted Diseases"},{"issue":"6","key":"10.1002\/14651858.CD010285.pub3-BIB0072|cit72","first-page":"885","article-title":"Treatment of pelvic inflammatory disease. Effects of lymecycline and clindamycin","volume":"29","author":"Gjonnaess","year":"1981","journal-title":"Current Therapeutic Research"},{"issue":"6","key":"10.1002\/14651858.CD010285.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/BF01640921","article-title":"Bacampicillin in the treatment of pelvic inflammatory disease: a study of two dosage regimens","volume":"8","author":"Grafford","year":"1980","journal-title":"Infection"},{"issue":"Suppl C","key":"10.1002\/14651858.CD010285.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/jac\/8.suppl_C.119","article-title":"Twice daily dosage of bacampicillin: a summary of clinical documentation","volume":"8","author":"Grafford","year":"1981","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD010285.pub3-BIB0075|cit75","first-page":"156","article-title":"A comparison of piperacillin and clindamycin plus gentamicin in women with pelvic infections","volume":"163","author":"Gunning","year":"1986","journal-title":"Surgery, Gynecology & Obstetrics"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD010285.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2165\/00003495-198600312-00004","article-title":"A comparison of parenteral sulbactam\/ampicillin versus clindamycin\/gentamicin in the treatment of pelvic inflammatory disease","volume":"31","author":"Gunning","year":"1986","journal-title":"Drugs"},{"issue":"3 Pt 1","key":"10.1002\/14651858.CD010285.pub3-BIB0077|cit77","first-page":"326","article-title":"Efficacy of oral antibiotics following parenteral antibiotics for serious infections in obstetrics and gynecology","volume":"73","author":"Hager","year":"1989","journal-title":"Obstetrics & Gynecology"},{"issue":"Suppl C","key":"10.1002\/14651858.CD010285.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/jac\/10.suppl_C.191","article-title":"A preliminary report on the use of ceftizoxime versus clindamycin\/tobramycin for the therapy of intra-abdominal and pelvic infections","volume":"10","author":"Harding","year":"1982","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD010285.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"S283","DOI":"10.1093\/clinids\/6.Supplement_1.S283","article-title":"Prospective, randomized, comparative trials in the therapy for intraabdominal and female genital tract infections","volume":"6","author":"Harding","year":"1984","journal-title":"Reviews of Infectious Diseases"},{"issue":"Suppl","key":"10.1002\/14651858.CD010285.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"S432","DOI":"10.1093\/clinids\/4.Supplement_2.S432","article-title":"Clinical experience with cefotaxime in obstetric and gynecologic infections","volume":"4","author":"Hemsell","year":"1982","journal-title":"Reviews of Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD010285.pub3-BIB0081|cit81","first-page":"223","article-title":"Piperacillin and a combination of clindamycin and gentamicin for the treatment of hospital and community acquired acute pelvic infections including pelvic abscess","volume":"165","author":"Hemsell","year":"1987","journal-title":"Surgery, Gynecology & Obstetrics"},{"issue":"Suppl 7","key":"10.1002\/14651858.CD010285.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2165\/00003495-198800357-00010","article-title":"Sulbactam\/ampicillin versus cefoxitin for uncomplicated and complicated acute pelvic inflammatory disease","volume":"35","author":"Hemsell","year":"1988","journal-title":"Drugs"},{"issue":"3 pt 2","key":"10.1002\/14651858.CD010285.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S0002-9378(16)44535-7","article-title":"Multicenter comparison of cefotetan and cefoxitin in the treatment of acute obstetric and gynecologic infections","volume":"158","author":"Hemsell","year":"1988","journal-title":"American Journal of Obstetrics & Gynecology"},{"issue":"10","key":"10.1002\/14651858.CD010285.pub3-BIB0084|cit84","first-page":"799","article-title":"Upper and lower reproductive tract bacteria in 126 women with acute pelvic inflammatory disease. Microbial susceptibility and clinical response to four therapeutic regimens","volume":"33","author":"Hemsell","year":"1988","journal-title":"Journal of Reproductive Medicine"},{"issue":"Suppl 7","key":"10.1002\/14651858.CD010285.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2165\/00003495-198800357-00010","article-title":"Sulbactam\/ampicillin versus cefoxitin for uncomplicated and complicated acute pelvic inflammatory disease","volume":"35","author":"Hemsell","year":"1988","journal-title":"Drugs"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD010285.pub3-BIB0086|cit86","first-page":"85D","article-title":"Single-agent therapy for acute pelvic inflammatory disease: sulbactam\/ampicillin versus cefoxitin","volume":"18","author":"Hemsell","year":"1990","journal-title":"Journal of International Medical Research"},{"issue":"1","key":"10.1002\/14651858.CD010285.pub3-BIB0087|cit87","first-page":"27","article-title":"Comparative bacteriology of parenteral single-agent vs. combination therapy in salpingitis","volume":"8","author":"Hemsell","year":"1991","journal-title":"Advances in Therapy"},{"issue":"3","key":"10.1002\/14651858.CD010285.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1155\/S1064744993000286","article-title":"Inpatient treatment for uncomplicated and complicated acute pelvic inflammatory disease: ampicillin\/sulbactam vs. cefoxitin","volume":"1","author":"Hemsell","year":"1993","journal-title":"Infectious Diseases in Obstetrics and Gynecology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD010285.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"S222","DOI":"10.1093\/clinids\/24.Supplement_2.S222","article-title":"A multicenter study comparing intravenous meropenem with clindamycin plus gentamicin for the treatment of acute gynecologic and obstetric pelvic infections in hospitalized women","volume":"24","author":"Hemsell","year":"1997","journal-title":"Clinical Infectious Diseases"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD010285.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"S703","DOI":"10.1093\/clinids\/7.Supplement_4.S703","article-title":"Overall clinical experience with aztreonam in the treatment of obstetric-gynecologic infections","volume":"7","author":"Henry","year":"1985","journal-title":"Reviews of Infectious Diseases"},{"issue":"6 Suppl","key":"10.1002\/14651858.CD010285.pub3-BIB0091|cit91","first-page":"595","article-title":"Infection in women. Clinical experience with beta-lactamase inhibitors","volume":"33","author":"Holloway","year":"1988","journal-title":"Journal of Reproductive Medicine"},{"issue":"3","key":"10.1002\/14651858.CD010285.pub3-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3109\/08860229009065564","article-title":"Safety, pharmacokinetics and efficacy of once-a-day netilmicin and amikacin versus their conventional schedules in patients suffering from pelvic inflammatory disease","volume":"12","author":"Ibrahim","year":"1990","journal-title":"Renal Failure"},{"issue":"5","key":"10.1002\/14651858.CD010285.pub3-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/(SICI)1098-0997(1997)5:5<319::AID-IDOG3>3.0.CO;2-Q","article-title":"Ampicillin\/sulbactam vs. cefoxitin for the treatment of pelvic inflammatory disease","volume":"5","author":"Jemsek","year":"1997","journal-title":"Infectious Diseases in Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD010285.pub3-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/BF01642234","article-title":"Pivampicillin treatment of urogenital infections in gynaecological patients. Clinical evaluation","volume":"2","author":"Jordheim","year":"1974","journal-title":"Infection"},{"issue":"3","key":"10.1002\/14651858.CD010285.pub3-BIB0095|cit95","first-page":"253","article-title":"Comparative study of ofloxacin+amoxicillin-clavulanic acid versus doxycycline+amoxicillin-clavulanic acid combination in the treatment of pelvic Chlamydia trachomatis infections","volume":"24","author":"Judlin","year":"1995","journal-title":"Journal de Gynecologie Obstetrique et Biologie de la Reproduction"},{"issue":"2","key":"10.1002\/14651858.CD010285.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00007611-198802000-00010","article-title":"Cefotetan: comparative and non comparative studies in obstetric and gynecologic infections","volume":"81","author":"Knuppel","year":"1988","journal-title":"Southern Medical Journal"},{"issue":"8","key":"10.1002\/14651858.CD010285.pub3-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1128\/AAC.35.8.1651","article-title":"Treatment of acute pelvic inflammatory disease in the ambulatory setting: trial of cefoxitin and doxycycline versus ampicillin-sulbactam","volume":"35","author":"Kosseim","year":"1991","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"3","key":"10.1002\/14651858.CD010285.pub3-BIB0098|cit98","first-page":"159","article-title":"Comparison of ceftriaxone plus ornidazole, ceftazidime plus ornidazole, and ornidazole in the treatment of pelvic inflammatory disease (PID)","volume":"5","author":"Kotoulas","year":"1992","journal-title":"Chemotherapy"},{"issue":"4","key":"10.1002\/14651858.CD010285.pub3-BIB0099|cit99","first-page":"225","article-title":"Sequential therapy with ciprofloxacin i.v.\/p.o. and metronidazole compared with cefotiam and metronidazole in the treatment of gynecological infections","volume":"3","author":"Kunzig","year":"1990","journal-title":"Chemotherapy"},{"issue":"1","key":"10.1002\/14651858.CD010285.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/BF01677396","article-title":"Treatment of salpingitis with pivampicillin. A comparison of twice-daily and thrice-daily dosages","volume":"8","author":"Kvile","year":"1980","journal-title":"Infection"},{"issue":"1","key":"10.1002\/14651858.CD010285.pub3-BIB0101|cit101","first-page":"77","article-title":"Comparison of cefoxitin and clindamycin-gentamicin for pelvic infections","volume":"9","author":"Voise","year":"1986","journal-title":"Clinical Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD010285.pub3-BIB0102|cit102","first-page":"90","article-title":"Efficacy and tolerability of imipenem-cilastatin versus clindamycin+gentamicin for serious pelvic infections","volume":"14","author":"Larsen","year":"1992","journal-title":"Clinical Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD010285.pub3-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0002-9378(92)91661-S","article-title":"Pelvic inflammatory disease: findings during inpatient treatment of clinically severe, laparoscopy-documented disease","volume":"166","author":"Hill","year":"1992","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"10","key":"10.1002\/14651858.CD010285.pub3-BIB0104|cit104","first-page":"754","article-title":"Multicenter randomized controlled clinical study on levornidazole and sodium chloride injection in the treatment of pelvic anaerobic infections [in Chinese]","volume":"45","author":"Ma","year":"2010","journal-title":"Chinese Journal of Obstetrics & Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD010285.pub3-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1179\/joc.1998.10.2.114","article-title":"Treatment of obstetric and gynecologic infections with meropenem: comparison with imipenem\/cilastatin","volume":"10","author":"Maggioni","year":"1998","journal-title":"Journal of Chemotherapy"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD010285.pub3-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"S298","DOI":"10.1007\/BF01646260","article-title":"A comparative clinical trial of sisomicin and gentamicin in major gram-negative infections","volume":"7","author":"Maki","year":"1979","journal-title":"Infection"},{"issue":"5","key":"10.1002\/14651858.CD010285.pub3-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1155\/1993\/567478","article-title":"A prospective randomized trial of imipenem-cilastatin versus clindamycin\/tobramycin in the treatment of intra-abdominal and pelvic infections","volume":"4","author":"Mandell","year":"1993","journal-title":"Canadian Journal of Infectious Diseases"},{"issue":"11","key":"10.1002\/14651858.CD010285.pub3-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1001\/archinte.1982.00340240022005","article-title":"Piperacillin v carbenicillin in the therapy for serious infections","volume":"142","author":"Marier","year":"1982","journal-title":"Archives of Internal Medicine"},{"issue":"Suppl A","key":"10.1002\/14651858.CD010285.pub3-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/jac\/9.suppl_A.149","article-title":"Effectiveness of mezlocillin in female genital tract infections","volume":"9","author":"Marshall","year":"1982","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"9","key":"10.1002\/14651858.CD010285.pub3-BIB0110|cit110","first-page":"1641","article-title":"Comparative clinical study of CS-807 (cefpodoxime proxetil) and bacampicillin (BAPC) on the infectious disease in the field of obstetrics and gynecology [in Japanese]","volume":"4","author":"Matsuda","year":"1988","journal-title":"Rinsho Iyaku (Journal of Clinical Therapeutics and Medicines)"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD010285.pub3-BIB0111|cit111","first-page":"667","article-title":"Comparative double-blind clinical trial of ceftibuten (7432-S) and bacampicillin (BAPC) against gynecological infections [in Japanese]","volume":"37","author":"Matsuda","year":"1989","journal-title":"Chemotherapy"},{"issue":"2","key":"10.1002\/14651858.CD010285.pub3-BIB0112|cit112","first-page":"87","article-title":"Comparison of ceftriaxone plus weekly azithromycin or daily ofloxacin for outpatient treatment of pelvic inflammatory disease: a randomized clinical trial","volume":"2","author":"Moghtadaei","year":"2008","journal-title":"Journal of Family and Reproductive Health"},{"issue":"2","key":"10.1002\/14651858.CD010285.pub3-BIB0113|cit113","first-page":"87","article-title":"Comparison of ceftriaxone plus weekly azithromycin or daily ofloxacin for outpatient treatment of pelvic inflammatory disease: a randomized clinical trial","volume":"2","author":"Moghtadaei","year":"2008","journal-title":"Journal of Family and Reproductive Health"},{"key":"10.1002\/14651858.CD010285.pub3-BIB0114|cit114","unstructured":"A clinical study on Qianjin capsule of gynaecology combined with antibiotics for pelvic inflammatory diseases (damp-heat stasis and Qi deficiency syndrome) clinicaltrials.gov\/ct2\/show\/NCT04031664 2019"},{"key":"10.1002\/14651858.CD010285.pub3-BIB0115|cit115","unstructured":"A clinical study on Kangfu anti-inflammatory suppository of gynaecology combined with antibiotics for pelvic inflammatory diseases (evidence of dampness and heat accumulation): a randomized, double blind, parallel Control of positive drugs, multi-center clinical study clinicaltrials.gov\/ct2\/show\/study\/NCT04035785"},{"issue":"5","key":"10.1002\/14651858.CD010285.pub3-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1067\/mob.2002.121625","article-title":"Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) randomized trial","volume":"186","author":"Ness","year":"2002","journal-title":"American Journal of Obstetric and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD010285.pub3-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/01.AOG.0000175193.37531.6e","article-title":"Effectiveness of treatment strategies of some women with pelvic inflammatory disease a randomized trial","volume":"106","author":"Ness","year":"2005","journal-title":"Obstetrics and Gynaecology"},{"issue":"8","key":"10.1002\/14651858.CD010285.pub3-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1001\/archsurg.1986.01400080033005","article-title":"Cefoxitin plus tobramycin and clindamycin plus tobramycin. A prospective randomized comparison in the therapy of mixed aerobic\/anaerobic infections","volume":"121","author":"Nicolle","year":"1986","journal-title":"Archives of Surgery"},{"issue":"3","key":"10.1002\/14651858.CD010285.pub3-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0020-7292(85)90100-6","article-title":"Factors predicting abnormal hysterosalpingographic findings in patients treated for acute pelvic inflammatory disease","volume":"23","author":"Paavonen","year":"1985","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"79","key":"10.1002\/14651858.CD010285.pub3-BIB0120|cit120","first-page":"161","article-title":"Comparison of ticarcillin plus clavulanic acid with cefoxitin in the treatment of female pelvic infection","volume":"29","author":"Aldridge","year":"1985","journal-title":"American Journal of Medicine"},{"issue":"6A Suppl","key":"10.1002\/14651858.CD010285.pub3-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"67S","DOI":"10.1016\/S0002-9610(98)00223-2","article-title":"Treatment of acute gynecologic infections with trovafloxacin. Trovafloxacin Surgical Group","volume":"178","author":"Roy","year":"1998","journal-title":"American Journal of Surgery"},{"issue":"5","key":"10.1002\/14651858.CD010285.pub3-BIB0122|cit122","first-page":"202","article-title":"Comparative multicenter study between meropenem versus clindamycin with gentamicin for the treatment of inpatient with obstetrics and\/or gynecologic infections","volume":"26","author":"Ruiz Conde","year":"1999","journal-title":"Clinica e Investigacion en Ginecologia y Obstetricia"},{"key":"10.1002\/14651858.CD010285.pub3-BIB0123|cit123","first-page":"53","article-title":"Mezlocillin versus penicillin and tobramycin in adolescent pelvic inflammatory disease: a prospective study","volume":"4","author":"Sanfilippo","year":"1989","journal-title":"Internal Pediatrics"},{"issue":"5","key":"10.1002\/14651858.CD010285.pub3-BIB0124|cit124","first-page":"554","article-title":"A comparison of netilmicin and gentamicin in the treatment of pelvic infections","volume":"54","author":"Schnider","year":"1979","journal-title":"Obstetrics & Gynecology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD010285.pub3-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2165\/00003495-198600312-00005","article-title":"Sulbactam\/ampicillin versus cefoxitin in the treatment of obstetric and gynaecological infections","volume":"31","author":"Senft","year":"1986","journal-title":"Drugs"},{"issue":"1","key":"10.1002\/14651858.CD010285.pub3-BIB0126|cit126","first-page":"41","article-title":"Medical treatment of pelvic inflammatory disease. A clinical study on the therapeutic effectiveness of piperacillin + erythromycin and of piperacillin + clindamycin + gentamycin","volume":"132","author":"Sesti","year":"1990","journal-title":"La Clinica Terapeutica"},{"issue":"2","key":"10.1002\/14651858.CD010285.pub3-BIB0127|cit127","first-page":"66","article-title":"Comparison of ofloxacin and ornidazole with probiotic versus doxycycline and metronidazole for the outpatient treatment of pelvic inflammatory disease","volume":"9","author":"Sharma","year":"2007","journal-title":"JK Science"},{"key":"10.1002\/14651858.CD010285.pub3-BIB0128|cit128","first-page":"196","article-title":"Imipenen\/cilastatin in the treatment of pelvic infections","volume":"47","author":"Silva","year":"1990","journal-title":"Revista Brasileira de Medicina"},{"issue":"3","key":"10.1002\/14651858.CD010285.pub3-BIB0129|cit129","first-page":"125","article-title":"Comparative study of intravenous azithromycin alone or intravenous and oral azithromycin for the treatment of pelvic inflammatory disease caused by Chlamydia trachomatis [in Croatian]","volume":"23","author":"Skerk","year":"2003","journal-title":"Croatian Journal of Infection"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD010285.pub3-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/00007435-198104000-00026","article-title":"Randomized prospective comparison of ampicillin and doxycycline in the treatment of acute pelvic inflammatory disease in hospitalized patients","volume":"8","author":"Spence","year":"1981","journal-title":"Sexually Transmitted Diseases"},{"issue":"9","key":"10.1002\/14651858.CD010285.pub3-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJM198403013100901","article-title":"Effect of treatment regimens for Neisseria gonorrhoeae on simultaneous infection with Chlamydia trachomatis","volume":"310","author":"Stamm","year":"1984","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD010285.pub3-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0924-8579(95)00055-0","article-title":"Sulbactam\/ampicillin versus cefoxitin in the treatment of gynaecological infection: an antibiotic therapeutic study","volume":"6","author":"Stiglmayer","year":"1996","journal-title":"International Journal of Antimicrobial Agents"},{"issue":"3","key":"10.1002\/14651858.CD010285.pub3-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0002-9378(16)44537-0","article-title":"Treatment of hospitalized patients with acute pelvic inflammatory disease: comparison of cefotetan plus doxycycline and cefoxitin plus doxycycline","volume":"158","author":"Sweet","year":"1988","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD010285.pub3-BIB0134|cit134","first-page":"280","article-title":"Piperacillin and tazobactam versus clindamycin and gentamicin in the treatment of hospitalized women with pelvic infection","volume":"83","author":"Sweet","year":"1994","journal-title":"Obstetrics & Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD010285.pub3-BIB0135|cit135","first-page":"31","article-title":"Comparative clinical study of ofloxacin (OFLX) and amoxicillin (AMPC) of the infectious disease in the field of obstetrics and gynecology [in Japanese]","volume":"34","author":"Takase","year":"1986","journal-title":"Chemotherapy"},{"issue":"4","key":"10.1002\/14651858.CD010285.pub3-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1089\/109629602762539535","article-title":"Ertapenem versus piperacillin-tazobactam for treatment of mixed anaerobic complicated intra-abdominal, complicated skin and skin structure, and acute pelvic infections","volume":"3","author":"Tellado","year":"2002","journal-title":"Surgical Infection Society"},{"issue":"4","key":"10.1002\/14651858.CD010285.pub3-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1089\/109629602762539535","article-title":"Ertapenem versus piperacillin-tazobactam for treatment of mixed anaerobic complicated intra-abdominal, complicated skin and skin structure, and acute pelvic infections","volume":"3","author":"Tellado","year":"2002","journal-title":"Surgical Infection Society"},{"issue":"4","key":"10.1002\/14651858.CD010285.pub3-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1089\/109629602762539553","article-title":"Surgical infections with enterococcus: outcome in patients treated with ertapenem versus piperacillin-tazobactam","volume":"3","author":"Teppler","year":"2002","journal-title":"Surgical Infection Society"},{"issue":"2","key":"10.1002\/14651858.CD010285.pub3-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0002-9378(80)90592-X","article-title":"The microbiology and therapy of acute pelvic inflammatory disease","volume":"136","author":"Thompson SE","year":"1980","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD010285.pub3-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0002-9378(85)80036-3","article-title":"High failure rates in outpatient treatment of salpingitis with either tetracycline alone or penicillin\/ampicillin combination","volume":"152","author":"Thompson","year":"1985","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD010285.pub3-BIB0141|cit141","first-page":"71","article-title":"Safety and efficacy of aminoglycosides once-a-day: experimental data and randomized controlled evaluation in patients suffering from pelvic inflammatory disease","volume":"1","author":"Tulkens","year":"1988","journal-title":"Journal of Drug Development"},{"issue":"Suppl C","key":"10.1002\/14651858.CD010285.pub3-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/jac\/27.suppl_C.49","article-title":"Pharmacokinetic and toxicological evaluation of a once-daily regimen versus conventional schedules of netilmicin and amikacin","volume":"27","author":"Tulkens","year":"1991","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD010285.pub3-BIB0143|cit143","first-page":"13","article-title":"A comparative trial of ceftriaxone and a penicillin\/chloramphenicol combination in gynaecological infections complicated by peritonitis","volume":"Suppl 2","author":"Van Gelderen","year":"1987","journal-title":"South African Medical Journal"},{"issue":"2","key":"10.1002\/14651858.CD010285.pub3-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00007435-199118020-00012","article-title":"Comparison of cefotetan plus doxycycline with cefoxitin plus doxycycline in the inpatient treatment of acute salpingitis","volume":"18","author":"Walker","year":"1991","journal-title":"Sexually Transmitted Diseases"},{"issue":"4 Suppl","key":"10.1002\/14651858.CD010285.pub3-BIB0145|cit145","first-page":"882","article-title":"Comparison of ceftizoxime versus combination therapy in the treatment of pelvic inflammatory disease (PID)","volume":"1","author":"Wikler","year":"1989","journal-title":"Journal of Chemotherapy"},{"issue":"2","key":"10.1002\/14651858.CD010285.pub3-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0028-2243(93)90180-K","article-title":"A comparison of pefloxacin\/metronidazole and doxycycline\/metronidazole in the treatment of laparoscopically confirmed acute pelvic inflammatory disease","volume":"50","author":"Witte","year":"1993","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"issue":"1","key":"10.1002\/14651858.CD010285.pub3-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1300\/J100v04n01_06","article-title":"Cost-effectiveness of ampicillin\/sulbactam versus cefoxitin in the treatment of pelvic inflammatory disease","volume":"4","author":"Wynd","year":"1999","journal-title":"Journal of Infectious Disease Pharmacotherapy"},{"issue":"10","key":"10.1002\/14651858.CD010285.pub3-BIB0148|cit148","first-page":"4665","article-title":"Effectiveness of Honghua Ruyi Wan combined with antibiotics for relief of pelvic inflammatory disease pain in women","volume":"28","author":"Zhang","year":"2017","journal-title":"Biomedical Research"},{"issue":"9","key":"10.1002\/14651858.CD010285.pub3-BIB0149|cit149","first-page":"11754","article-title":"Effects of levofloxacin hydrochloride and ciprofloxacin on pelvic inflammation and risk factors related to their effects","volume":"12","author":"Zou","year":"2019","journal-title":"International Journal of Clinical and Experimental Medicine"},{"issue":"4","key":"10.1002\/14651858.CD010285.pub3-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1136\/sti.2010.048694","article-title":"What is the cost of pelvic inflammatory disease and how much could be prevented by screening for chlamydia trachomatis? Cost analysis of the Prevention of Pelvic Infection (POPI) trial","volume":"87","author":"Aghaizu","year":"2011","journal-title":"Sexually Transmitted Infections"},{"issue":"7168","key":"10.1002\/14651858.CD010285.pub3-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1136\/bmj.317.7168.1309","article-title":"Confidence intervals for the number needed to treat","volume":"317","author":"Altman","year":"1998","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD010285.pub3-BIB0152|cit152","unstructured":"Ross J Cole M Evans C \u00a0 Lyons D Dean G Cousins D United Kingdom national guideline for the management of pelvic inflammatory disease (2019 interim update) www.bashhguidelines.org\/media\/1217\/pid-update-2019.pdf"},{"key":"10.1002\/14651858.CD010285.pub3-BIB0153|cit153","first-page":"121","article-title":"A study of bacterial pathogens in acute pelvic inflammatory disease","volume":"88","author":"Baveja","year":"2001","journal-title":"Journal of Communicable Diseases"},{"issue":"10","key":"10.1002\/14651858.CD010285.pub3-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.2105\/AJPH.88.10.1496","article-title":"The evolving epidemiology of chlamydial and gonococcal infections in response to control programs in Winnipeg, Canada","volume":"88","author":"Blanchard","year":"1998","journal-title":"American Journal of Public Health"},{"key":"10.1002\/14651858.CD010285.pub3-BIB0155|cit155","unstructured":"Centers for Disease Control and Prevention Sexually transmitted disease surveillance 2018 www.cdc.gov\/std\/stats18\/womenandinf.htm#pid"},{"issue":"2","key":"10.1002\/14651858.CD010285.pub3-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/OLQ.0b013e31823e2ff7","article-title":"Chlamydia trachomatis trends in the United States among persons 14 to 39 years of age, 1999-2008","volume":"39","author":"Datta","year":"2012","journal-title":"Sexually Transmitted Diseases"},{"key":"10.1002\/14651858.CD010285.pub3-BIB0157|cit157","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2010\/847041","article-title":"Tuboovarian abscess: is size associated with duration of hospitalization and complications?","volume":"2010","author":"DeWitt","year":"2010","journal-title":"Obstetrics and Gynecology International"},{"issue":"629","key":"10.1002\/14651858.CD010285.pub3-BIB0158|cit158","first-page":"634","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD010285.pub3-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJM197507242930403","article-title":"Polymicrobial etiology of acute pelvic inflammatory disease","volume":"293","author":"Eschenbach","year":"1975","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD010285.pub3-BIB0160|cit160","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1136\/adc.2007.127316","article-title":"How much loss to follow-up is acceptable in long-term randomised trials and prospective studies?","volume":"93","author":"Fewtrell","year":"2008","journal-title":"Archives of Disease in Childhood"},{"issue":"7","key":"10.1002\/14651858.CD010285.pub3-BIB0161|cit161","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1136\/sextrans-2015-052195","article-title":"Population attributable fraction of pelvic inflammatory disease associated with chlamydia and gonorrhoea: a cross-sectional analysis of Australian sexual health clinic data","volume":"92","author":"Goller","year":"2016","journal-title":"Sexually Transmitted Infections"},{"key":"10.1002\/14651858.CD010285.pub3-BIB0162|cit162","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT 2014"},{"issue":"1","key":"10.1002\/14651858.CD010285.pub3-BIB0163|cit163","first-page":"113","article-title":"Criteria for diagnosis and grading of salpingitis [editorial]","volume":"61","author":"Hager","year":"1983","journal-title":"Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD010285.pub3-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1586\/14787210.4.2.235","article-title":"Epidemiology, pathogenesis and treatment of pelvic inflammatory disease","volume":"4","author":"Haggerty","year":"2006","journal-title":"Expert Review of Anti-infective Therapy"},{"key":"10.1002\/14651858.CD010285.pub3-BIB0165|cit165","unstructured":"Higgins JP Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD010285.pub3-BIB0166|cit166","doi-asserted-by":"crossref","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ Cochrane Handbook for Systematic Reviews of Interventions\u00a0version 6.0 (updated July 2019) Available from www.training.cochrane.org\/handbook","DOI":"10.1002\/9781119536604"},{"issue":"1","key":"10.1002\/14651858.CD010285.pub3-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/QCO.0b013e328334de21","article-title":"Current concepts in managing pelvic inflammatory disease","volume":"23","author":"Judlin","year":"2010","journal-title":"Current Opinion in Infectious Diseases"},{"issue":"6","key":"10.1002\/14651858.CD010285.pub3-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/OLQ.0b013e3181676bbd","article-title":"Prevalence of sexually transmitted infections among sexually active Jordanian females","volume":"35","author":"Mahafzah","year":"2008","journal-title":"Sexually Transmitted Diseases"},{"issue":"4","key":"10.1002\/14651858.CD010285.pub3-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00007435-197710000-00001","article-title":"Acute pelvic inflammatory disease: characteristics of patients with gonococcal and nongonococcal infection and evaluation of their response to treatment with aqueous procaine penicillin G and spectinomycin hydrochloride","volume":"4","author":"McCormack","year":"1977","journal-title":"Sexually Transmitted Diseases"},{"key":"10.1002\/14651858.CD010285.pub3-BIB0170|cit170","first-page":"875","article-title":"Observer agreement with laparoscopic diagnosis of pelvic inflammatory disease using photographs","volume":"101","author":"Molander","year":"2003","journal-title":"Obstetrics and Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD010285.pub3-BIB0171|cit171","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1136\/sextrans-2014-051646","article-title":"A cross-sectional study showing differences in the clinical diagnosis of pelvic inflammatory disease according to the experience of clinicians: implications for training and audit","volume":"90","author":"Morris","year":"2014","journal-title":"Sexually Transmitted Infections"},{"issue":"3","key":"10.1002\/14651858.CD010285.pub3-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/01.olq.0000187205.67390.d1","article-title":"Prediction of pelvic inflammatory disease among young, single, sexually active women","volume":"33","author":"Ness","year":"2006","journal-title":"Sexually Transmitted Diseases"},{"issue":"12","key":"10.1002\/14651858.CD010285.pub3-BIB0173|cit173","doi-asserted-by":"publisher","first-page":"e0143304","DOI":"10.1371\/journal.pone.0143304","article-title":"Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting","volume":"10","author":"Newman","year":"2015","journal-title":"PloS One"},{"issue":"1","key":"10.1002\/14651858.CD010285.pub3-BIB0174|cit174","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1017\/S0950268816002065","article-title":"Pelvic inflammatory disease and salpingitis: incidence of primary and repeat episodes in England","volume":"145","author":"Price","year":"2017","journal-title":"Epidemiology and Infection"},{"key":"10.1002\/14651858.CD010285.pub3-BIB0175|cit175","unstructured":"The Cochrane Collaboration Review Manager Web (RevMan Web) 2019"},{"issue":"4","key":"10.1002\/14651858.CD010285.pub3-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/sti.2004.009548","article-title":"What is endometritis and does it require treatment?","volume":"80","author":"Ross","year":"2004","journal-title":"Sexually Transmitted Infections"},{"key":"10.1002\/14651858.CD010285.pub3-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1258\/095646207782193911","article-title":"European guidelines of the management of pelvic inflammatory disease","volume":"18","author":"Ross","year":"2007","journal-title":"International Journal of STD and AIDS"},{"issue":"10","key":"10.1002\/14651858.CD010285.pub3-BIB0178|cit178","first-page":"725","article-title":"Pelvic inflammatory disease","volume":"90","author":"Ross","year":"2014","journal-title":"American Family Physician"},{"issue":"1","key":"10.1002\/14651858.CD010285.pub3-BIB0179|cit179","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/0956462413498714","article-title":"2012 European guideline for the management of pelvic inflammatory disease","volume":"25","author":"Ross","year":"2014","journal-title":"International Journal of STD & AIDS"},{"key":"10.1002\/14651858.CD010285.pub3-BIB0180|cit180","doi-asserted-by":"publisher","first-page":"548","DOI":"10.2471\/BLT.18.228486","article-title":"Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016","volume":"97","author":"Rowley","year":"2019","journal-title":"Bulletin of the World Health Organization"},{"issue":"7","key":"10.1002\/14651858.CD010285.pub3-BIB0181|cit181","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1258\/0956462991914447","article-title":"The rate of diagnosis and demography of pelvic inflammatory disease in general practice: England and Wales","volume":"10","author":"Simms","year":"1999","journal-title":"International Journal of STD and AIDS"},{"issue":"5","key":"10.1002\/14651858.CD010285.pub3-BIB0182|cit182","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/0002-9378(91)91474-B","article-title":"Diagnosis and laparoscopic grading of acute salpingitis","volume":"164","author":"Soper","year":"1991","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"2 Pt 1","key":"10.1002\/14651858.CD010285.pub3-BIB0183|cit183","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/AOG.0b013e3181e92c54","article-title":"Pelvic inflammatory disease","volume":"116","author":"Soper","year":"2010","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD010285.pub3-BIB0184|cit184","doi-asserted-by":"crossref","unstructured":"Sterne J Why the Cochrane risk of bias tool should not include funding source as a standard item [editorial] Cochrane Database of Systematic Reviews 2013 12 ED000076","DOI":"10.1002\/14651858.ED000076"},{"issue":"5","key":"10.1002\/14651858.CD010285.pub3-BIB0185|cit185","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/sim.2934","article-title":"Recent developments in meta-analysis","volume":"27","author":"Sutton","year":"2008","journal-title":"Statistics in Medicine"},{"issue":"4","key":"10.1002\/14651858.CD010285.pub3-BIB0186|cit186","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/OLQ.0b013e3181fc6c65","article-title":"Estimating the direct costs of pelvic inflammatory disease in adolescents: a within-system analysis","volume":"38","author":"Trent","year":"2011","journal-title":"Sexually Transmitted Diseases"},{"issue":"4","key":"10.1002\/14651858.CD010285.pub3-BIB0187|cit187","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/infdis\/168.4.969","article-title":"Pelvic inflammatory disease: metaanalysis of antimicrobial regimen efficacy","volume":"168","author":"Walker","year":"1993","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD010285.pub3-BIB0188|cit188","first-page":"S29","article-title":"Antibiotic therapy for acute pelvic inflammatory disease: the 2006 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines","volume":"28 (Suppl 1)","author":"Walker","year":"2007","journal-title":"Clinical Infectious Diseases"},{"issue":"RR-03","key":"10.1002\/14651858.CD010285.pub3-BIB0189|cit189","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2015","volume":"64","author":"Workowski","year":"2015","journal-title":"MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report"},{"issue":"1","key":"10.1002\/14651858.CD010285.pub3-BIB0190|cit190","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010285","article-title":"Antibiotic therapy for pelvic inflammatory disease (PID)","author":"Savaris","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD010285.pub3-BIB0191|cit191","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010285.pub2","article-title":"Antibiotic therapy for pelvic inflammatory disease","author":"Savaris","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T08:29:54Z","timestamp":1634804994000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD010285.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane STI Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,8,20]]},"references-count":191,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,8]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010285.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,20]]}}}